temozolomide has been researched along with adrenomedullin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, Z; Huang, L; Kong, L; Li, H; Li, M; Liu, F; Wang, D; Wei, Y; Xiao, F; Zhang, H; Zhang, W; Zhao, H | 1 |
| Cao, D; Chen, L; Cheng, M; He, Z; Hu, J; Liu, L; Liu, P; Tang, J | 1 |
2 other study(ies) available for temozolomide and adrenomedullin
| Article | Year |
|---|---|
Inhibition of Intermedin (Adrenomedullin 2) Suppresses the Growth of Glioblastoma and Increases the Antitumor Activity of Temozolomide.
Topics: Adrenomedullin; Animals; Female; Glioblastoma; Humans; Mice; Mice, Nude; Temozolomide | 2021 |
miR-1297 sensitizes glioma cells to temozolomide (TMZ) treatment through targeting adrenomedullin (ADM).
Topics: Adrenomedullin; Animals; Antineoplastic Agents, Alkylating; Apoptosis; bcl-2-Associated X Protein; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Eosine Yellowish-(YS); Glioma; Hematoxylin; Mice; MicroRNAs; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Temozolomide | 2022 |